ICON Public Limited Company Dividend History (ICLR)
ICON Public Limited Company does not pay dividends currently 😔
They might in the future, check back soon!
About ICON Public Limited Company
ICON Public Limited Company is a global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1990 and headquartered in Dublin, Ireland, ICON supports its clients in advancing drugs and medical devices through clinical trials and regulatory aspects to market launch. The company is well-regarded for its expertise in clinical development, and it provides services across a broad range of therapeutic areas. As of the latest updates, the CEO of ICON is Steve Cutler, who has played a significant role in steering the company's growth and innovation in the life sciences sector. ICON has made substantial revenues, reporting over $5 billion in recent fiscal years, reflecting its efficiency and significance in the industry. The company employs a diverse workforce across its numerous locations worldwide, making it a notable player in the global clinical research landscape.
Charles River Laboratories International, Inc.
IQVIA Holdings Inc.The global onco-hematology molecular testing market is expected to grow significantly, driven by the increasing incidence of hematological cancers and advancements in molecular diagnostic technologies. This market is poised to reach $1.5 billion by 2031, with a CAGR of 12.5%.
GlobeNewswire Inc. · Published on Fri Oct 04 2024The global vaccine contract manufacturing market is expected to grow from $2.8 billion in 2023 to $6.1 billion by 2032, driven by increased demand for outsourcing vaccine production and technological advancements.
GlobeNewswire Inc. · Published on Thu Sep 05 2024